NCT02099058 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Filter rows:

Showing 1 to 36 of 36 entries

Facility	City	State	Zip	Country	Details
AP-HM - Hopital de la Timone /ID# 151570	Marseille CEDEX 05	Bouches-du-Rhone	13385	France	Details
Asan Medical Center /ID# 217334	Seoul	Seoul Teugbyeolsi	05505	Korea, Republic of	Details
China Medical University Hospital /ID# 217494	Taichung		40447	Taiwan	Details
City of Hope /ID# 153759	Duarte	California	91010	United States	Details
Dana-Farber Cancer Institute /ID# 168782	Boston	Massachusetts	02215	United States	Details
Duke Cancer Center /ID# 123763	Durham	North Carolina	27710-3000	United States	Details
Duplicate_Henry Ford Health System /ID# 149857	Detroit	Michigan	48202	United States	Details
Duplicate_Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRCCS /ID# 164077	Meldola	Emilia-Romagna	47014	Italy	Details
Duplicate_Tampere University Hospital /ID# 165065	Tampere	Pirkanmaa	33520	Finland	Details
Duplicate_The Catholic University of Korea, ST. Vincent's Hospital /ID# 233378	Suwon	Gyeonggido	16247	Korea, Republic of	Details
Herbert Herman Cancer Center /ID# 149858	Lansing	Michigan	48912	United States	Details
Ingalls Memorial Hosp /ID# 165876	Harvey	Illinois	60426	United States	Details
Institut Gustave Roussy /ID# 132747	Villejuif Cedex	Val-de-Marne	94805	France	Details
Mary Crowley Cancer Research /ID# 123760	Dallas	Texas	75230	United States	Details
Massachusetts General Hospital /ID# 129804	Boston	Massachusetts	02114	United States	Details
Montefiore Medical Park at Eastchester /ID# 218445	Bronx	New York	10461	United States	Details
National Cancer Center Hospital /ID# 217571	Chuo-ku	Tokyo	104-0045	Japan	Details
National Cancer Center Hospital East /ID# 217570	Kashiwa-shi	Chiba	277-8577	Japan	Details
National Cheng Kung University Hospital /ID# 167175	Tainan		704	Taiwan	Details
National Taiwan University Hospital /ID# 167173	Taipei City	Taipei	100	Taiwan	Details
Northwell Health - Monter Cancer Center /ID# 218170	Lake Success	New York	11042	United States	Details
Radboud Universitair Medisch Centrum /ID# 246908	Nijmegen	Gelderland	6525 GA	Netherlands	Details
Scottsdale Healthcare /ID# 123761	Scottsdale	Arizona	85258-4566	United States	Details
Summit Medical Group-Florham Park /ID# 217651	Florham Park	New Jersey	07932-1049	United States	Details
Taipei Veterans General Hosp /ID# 217392	Taipei		11217	Taiwan	Details
Tennessee Oncology, PLLC /ID# 129802	Nashville	Tennessee	37203	United States	Details
The University of Chicago Medical Center /ID# 136995	Chicago	Illinois	60637-1443	United States	Details
UC Irvine /ID# 165107	Orange	California	92868	United States	Details
Univ of Colorado Cancer Center /ID# 123759	Aurora	Colorado	80045	United States	Details
Universitair Ziekenhuis Antwerpen /ID# 170118	Edegem	Antwerpen	2650	Belgium	Details
University of California, Davis Comprehensive Cancer Center /ID# 129805	Sacramento	California	95817	United States	Details
University of California, Los Angeles /ID# 148295	Los Angeles	California	90095	United States	Details
University of Texas MD Anderson Cancer Center /ID# 154648	Houston	Texas	77030	United States	Details
Virginia Cancer Specialists - Fairfax /ID# 165708	Fairfax	Virginia	22031	United States	Details
Washington University-School of Medicine /ID# 143798	Saint Louis	Missouri	63110	United States	Details
Yonsei University Health System Severance Hospital /ID# 217333	Seoul		03722	Korea, Republic of	Details

Showing 1 to 36 of 36 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT ID	NCT02099058
Title	A Phase 1/1b Study With ABBV-399, an Antibody Drug Conjugate, in Subjects With Advanced Solid Cancer Tumors
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	AbbVie
Indications	Advanced Solid Tumor
Therapies	Carboplatin + Telisotuzumab vedotin Erlotinib + Telisotuzumab vedotin Telisotuzumab vedotin Bevacizumab + Telisotuzumab vedotin Cetuximab + Telisotuzumab vedotin
Age Groups:	senior \| adult
Covered Countries	USA \| NLD \| ITA \| FRA \| FIN \| BEL

NCT02099058
Clinical Trial Detail

Contact

NCT02099058Clinical Trial Detail

Contact

NCT02099058
Clinical Trial Detail